drugset / Trial / NCT00834184
Safety and PK of Nikkomycin Z in Healthy Subjects
RandomizedSequentialTriple-blindTreatment
Summary
The purpose of this study is to determine if nikkomycin Z is safe when administered at different dose levels for 14 days. The study will also determine blood levels and urinary excretion of nikkomycin Z in relation to dose administered. Healthy patients will be eligible to participate and will be allocated to receive nikkomycin Z (various doses) or a placebo.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NIKKOMYCIN | Small molecule | 250 mg | — |
| Subject | NIKKOMYCIN | Small molecule | 500 mg | — |
| Subject | NIKKOMYCIN | Small molecule | 750 mg | — |
Indications
No indication recorded.